Article
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
14 Jul 2023
Abstract excerpt
SARS-CoV-2 Omicron subvariants have evolved to evade receptor-binding site (RBS) antibodies that exist in diverse individuals as public antibody clones. We rationally selected RBS antibodies resilient to mutations in emerging Omicron subvariants. Y489 was identified as a site of virus vulnerability and a common footprint of broadly neutralizing antibodies against the subvariants. Multiple Y489-binding antibodies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
